Results 11 to 20 of about 20,494 (185)

Methylation of BRD4 by PRMT1 regulates BRD4 phosphorylation and promotes ovarian cancer invasion

open access: yesCell Death and Disease, 2023
Bromodomain-containing protein 4 (BRD4), the major component of bromodomain and extra-terminal domain (BET) protein family, has important functions in early embryonic development and cancer development. However, the posttranslational modification of BRD4
Yi Liu   +8 more
doaj   +2 more sources

Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of small molecule inhibitor JQ1 [PDF]

open access: yesScientific Reports, 2017
The bromodomain protein Brd4 is an epigenetic reader and plays a critical role in the development and maintenance of leukemia. Brd4 binds to acetylated histone tails and activates transcription by recruiting the positive elongation factor P-TEFb.
Tim-Michael Decker   +6 more
doaj   +2 more sources

BRD4-mediated repression of p53 is a target for combination therapy in AML [PDF]

open access: yes, 2021
Acute myeloid leukemia (AML) is a typically lethal molecularly heterogeneous disease, with few broad-spectrum therapeutic targets. Unusually, most AML retain wild-type TP53, encoding the pro-apoptotic tumor suppressor p53.
McGarry, Lynn   +46 more
core   +2 more sources

Development of an N-Terminal BRD4 Bromodomain-Targeted Degrader [PDF]

open access: yes, 2021
Targeted protein degradation is a powerful induced-proximity tool to control cellular concentrations of native proteins using small molecules. However, the design of selectivity in protein degradation remains challenging.
Huda, Zahid   +5 more
core   +1 more source

Discovery of the natural product 3',4',7,8-tetrahydroxyflavone as a novel and potent selective BRD4 bromodomain 2 inhibitor

open access: yesJournal of Enzyme Inhibition and Medicinal Chemistry, 2021
Bromodomain-containing protein 4 (BRD4) binds acetylated lysine residues on the N-terminal tails of histones through two bromodomains (BD1 and BD2) to regulate gene transcription.
Jiao Li   +9 more
doaj   +1 more source

Bromodomain protein BRD4 is an epigenetic activator of B7-H6 expression in acute myeloid leukemia

open access: yesOncoImmunology, 2021
B7-H6, a ligand for the NK activating receptor NKp30, has been identified as a biomarker of poor prognosis in several solid cancers. However, little is known about the role of B7-H6 and the mechanisms that control its expression in acute myeloid leukemia
Aroa Baragaño Raneros   +7 more
doaj   +1 more source

Structural variation of protein-ligand complexes of the first bromodomain of BRD4 [PDF]

open access: yes, 2021
The bromodomain-containing protein 4 (BRD4), a member of the bromodomain and extra-terminal domain (BET) family, plays a key role in several diseases, especially cancers.
Ellen, Guest   +5 more
core   +5 more sources

Molecular Insight into Function of the Evolutionarily Conserved Brd4 Extraterminal Domain (ET) and Mechanism of Brd4 Functions in Human Diseases

open access: yes, 2012
Bromodomain protein 4 (Brd4) plays critical roles in development, cancer progression and virus-host pathogenesis. Papillomaviruses (PV) E2 protein associates with Brd4 and this interaction is important for transcriptional regulation of the viral ...
Rahman, Shaila
core   +6 more sources

Inducing DNA damage through R-loops to kill cancer cells

open access: yesMolecular & Cellular Oncology, 2021
R-loops are intermediate structures of transcription that can accumulate when transcriptional elongation is blocked by inhibiting BRD4. In normal cells, R-loop persistence suppresses firing of adjacent replication origins.
Fred C. Lam   +2 more
doaj   +1 more source

Diverse Amine-Acid Coupling Reactions Modulate the Potency of BRD4 PROTACs [PDF]

open access: yes, 2023
Protein degradation with proteolysis targeting chimeras (PROTACs) has emerged as a powerful therapeutic strate-gy. PROTACs are heterobifunctional molecules consisting of a target-binding moiety, a linker and an E3 ligase-binding moiety that are commonly ...
Andrew, McGrath   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy